Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination.

Moss RB, Wallace MR, Steigbigel RT, Morrison SA, Giermakowska WK, Nardo CJ, Diveley JP, Carlo DJ.

Clin Exp Immunol. 2002 May;128(2):359-64.

2.

Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis.

Morgan EE, Nardo CJ, Diveley JP, Kunin J, Bartholomew RM, Moss RB, Carlo DJ.

J Neurosci Res. 2001 May 1;64(3):298-301.

PMID:
11319774
3.

Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study.

Rose KM, Tyroler HA, Nardo CJ, Arnett DK, Light KC, Rosamond W, Sharrett AR, Szklo M.

Am J Hypertens. 2000 Jun;13(6 Pt 1):571-8.

PMID:
10912737
4.

Descriptive epidemiology of blood pressure response to change in body position. The ARIC study.

Nardo CJ, Chambless LE, Light KC, Rosamond WD, Sharrett AR, Tell GS, Heiss G.

Hypertension. 1999 May;33(5):1123-9.

PMID:
10334798
5.

T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides.

Moreland LW, Morgan EE, Adamson TC 3rd, Fronek Z, Calabrese LH, Cash JM, Markenson JA, Matsumoto AK, Bathon J, Matteson EL, Uramoto KM, Weyand CM, Koopman WJ, Heck LW, Strand V, Diveley JP, Carlo DJ, Nardo CJ, Richieri SP, Brostoff SW.

Arthritis Rheum. 1998 Nov;41(11):1919-29.

PMID:
9811045

Supplemental Content

Loading ...
Support Center